南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

LncRNA C9orf139通过miR-661/HDAC11轴调控食管鳞癌进展机制研究

LncRNA C9orf139 can regulate the progression of esophageal squamous carcinoma by mediating the miR-661/HDAC11 axis

Xiaojie Yang, Zhimin Shen, Mengyue Tian, Yukang Lin, Liming Li, Tianci Chai, Peipei Zhang, Mingqiang Kang, Jiangbo Lin

Journal:Translational Oncology

IF:4.8

DOI:10.1016/j.tranon.2022.101487

PMID:35917643

Published:2022-07-30

research field:分子生物学微生物组研究细胞生物学胃肠病学营养科学微生物学遗传学与基因组学代谢学宿主-微生物相互作用

Abstract

Increasing evidence has indicated that long non-coding RNAs (LncRNAs) play multiple functions in the development of cancer and function as indicators of diagnosis and prognosis. This aim of this study was to investigate the roles LncRNA C9orF139 had in the progression of esophageal squamous carcinoma (ESCC). We found C9orf139 was highly expressed in ESCC and knock down the expression of C9orf139 significantly suppressed cell proliferation, promoted apoptosis, and inhibited migration and invasion. C9orf139 was able to negatively regulate miR-661 expression. At the same time, HDAC11 expression was negatively regulated by miR-661. The C9orf139/miR-661/HDAC11 axis was further involved in regulating the expression of the NF-κB signaling pathway. The association between the C9orf139 knockdown and the reduced tumor growth and size was observed during in vivo study. C9orf139 is highly expressed in ESCC, and is thus qualified to be used as a potential diagnostic and prognostic marker for ESCC. Its promotion of ESCC progression is achieved by mediating the miR-661/HDAC11 axis.

本文使用的Yeasen产品

产品应用
购物车
客服
转染试用